Therapeutic effects of physostigmine during systemic inflammation
Katharina Effenberger-Neidnicht,1 Johannes Jägers,2 Rabea Verhaegh,1 Michael Kirsch1 1Institute of Physiological Chemistry, University Hospital Essen, Essen, Germany; 2Institute of Physiology, University Hospital Essen, Essen, Germany Introduction: Usually, physostigmine is used as antidote for ant...
Saved in:
Main Authors: | Effenberger-Neidnicht K (Author), Jägers J (Author), Verhaegh R (Author), Kirsch M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Moderate glucose supply reduces hemolysis during systemic inflammation
by: Jägers J, et al.
Published: (2018) -
Microvascular stasis and hemolysis: coincidence or causality?
by: Effenberger-Neidnicht K, et al.
Published: (2019) -
Physostigmine as an antinociceptive agent: a possible way to improve the safety of anesthesia
by: A. . Nemirovsky
Published: (2018) -
Delirium due to Anticholinergic Intoxication and Use of Physostigmine in Pediatric Emergency Room
by: Alper Çiçek, et al.
Published: (2022) -
In Vivo Effects of Neostigmine and Physostigmine on Neutrophil Functions and Evaluation of Acetylcholinesterase and Butyrylcholinesterase as Inflammatory Markers during Experimental Sepsis in Rats
by: Diane I. Bitzinger, et al.
Published: (2019)